| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |